Literature DB >> 16628004

M-phase MELK activity is regulated by MPF and MAPK.

Caroline Badouel1, Roman Körner, Marie Frank-Vaillant, Anne Couturier, Erich A Nigg, Jean-Pierre Tassan.   

Abstract

The protein kinase MELK is implicated in the control of cell proliferation, cell cycle and mRNA splicing. We previously showed that MELK activity is correlated with its phosphorylation level, is cell cycle dependent, and maximal during mitosis. Here we report on the identification of T414, T449, T451, T481 and S498 as residues phosphorylated in Xenopus MELK (xMELK) in M-phase egg extract. Phosphorylations of T449, T451, T481 are specifically detected during mitosis. Results obtained in vivo showed that MPF and MAPK pathways are involved in xMELK phosphorylation. In vitro, MPF and MAPK directly phosphorylate xMELK and MPF phosphorylates xMELK on T481. In addition, phosphorylation by MPF and MAPK enhances MELK activity in vitro. Taken together our results indicate that MELK phosphorylation by MPF and MAPK enhance its activity during M-phase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628004     DOI: 10.4161/cc.5.8.2683

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  22 in total

1.  Murine protein serine-threonine kinase 38 activates p53 function through Ser15 phosphorylation.

Authors:  Hyun-A Seong; Hyunjung Ha
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

2.  Targeting MEK/MELK in atypical teratoid rhabdoid tumor: a treatment approach aimed at exploiting blood-brain barrier deficiencies.

Authors:  Dean Popovski; Annie Huang
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

3.  Single-cell transcriptome sequencing reveals that cell division cycle 5-like protein is essential for porcine oocyte maturation.

Authors:  Xiao-Man Liu; Yan-Kui Wang; Yun-Hua Liu; Xiao-Xia Yu; Pei-Chao Wang; Xuan Li; Zhi-Qiang Du; Cai-Xia Yang
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

4.  Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells.

Authors:  Cenk Kig; Monique Beullens; Lijs Beke; Aleyde Van Eynde; Johannes T Linders; Dirk Brehmer; Mathieu Bollen
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

5.  Cortical localization of maternal embryonic leucine zipper kinase (MELK) implicated in cytokinesis in early xenopus embryos.

Authors:  Jean-Pierre Tassan
Journal:  Commun Integr Biol       Date:  2011-07-01

6.  Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway.

Authors:  Ichiro Nakano; Kaushal Joshi; Koppany Visnyei; Bin Hu; Momoko Watanabe; Diana Lam; Eric Wexler; Kuniyasu Saigusa; Yuko Nakamura; Dan R Laks; Paul S Mischel; Mariano Viapiano; Harley I Kornblum
Journal:  Neuro Oncol       Date:  2011-05-09       Impact factor: 12.300

7.  MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.

Authors:  Radoslav Janostiak; Navin Rauniyar; TuKiet T Lam; Jianhong Ou; Lihua J Zhu; Michael R Green; Narendra Wajapeyee
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.

Authors:  Chunyu Gu; Yeshavanth K Banasavadi-Siddegowda; Kaushal Joshi; Yuko Nakamura; Habibe Kurt; Snehalata Gupta; Ichiro Nakano
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

9.  Benzo[e]pyridoindoles, novel inhibitors of the aurora kinases.

Authors:  Thi My-Nhung Hoang; Bertrand Favier; Annie Valette; Caroline Barette; Chi Hung Nguyen; Laurence Lafanechère; David S Grierson; Stéfan Dimitrov; Annie Molla
Journal:  Cell Cycle       Date:  2009-03-18       Impact factor: 4.534

10.  The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.

Authors:  Ruprecht Kuner; Maria Fälth; Nicole Chui Pressinotti; Jan C Brase; Sabrina Balaguer Puig; Jennifer Metzger; Stephan Gade; Georg Schäfer; Georg Bartsch; Eberhard Steiner; Helmut Klocker; Holger Sültmann
Journal:  J Mol Med (Berl)       Date:  2012-09-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.